Companies: 10,795·Total market cap: $144.5T
PAVmed Inc.

PAVmed Inc.

PAVMNASDAQHealthcare● Active
$5.18
$-0.27(-4.95%)
Market Cap$2781852
P/E Ratio—
52W High$28.44
52W Low$4.99
Shares OutstandingFinancialsRevenue

PAVmed Inc. (PAVM) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

PAVM · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
670,466▲ +107.96% YoY Change
FY · as of Dec 31, 2025 · Reported in USD
vs 322,407 in FY 2024
Diluted Shares Outstanding
670,466
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+107.96%
year-over-year
Float (Free Float)
441,166
publicly tradable shares
82.2% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+50.2%
2022 → 2025
5-Year CAGRincreasing
+44.8%
2020 → 2025
10-Year CAGRincreasing
+36.6%
2015 → 2025
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 670,466
670,466
+107.96%
FY 2024
Diluted Shares: 2.2M
322,407
+33.75%
FY 2023
Diluted Shares: 241,052
241,052
+21.78%
FY 2022
Diluted Shares: 197,947
197,947
+14.91%
FY 2021
Diluted Shares: 172,257
172,257
+63.42%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs PAVM
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
PAVmed Inc.PAVM
PAVmed Inc.YOU
670,466—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

PAVmed Inc. (PAVM) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, PAVmed Inc. reports 670,466 basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

PAVmed Inc.'s basic shares outstanding (670,466) represents currently issued shares. Diluted shares outstanding (670,466) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

PAVmed Inc.'s float is 441,166 (82.2% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float441,166(82.2%)
Outstanding537,037

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

PAVmed Inc. (PAVM) shares outstanding history from 2014 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

PAVmed Inc. shares outstanding for the fiscal year ending December 31, 2025 were 670,466, a 107.96% increase year-over-year. PAVmed Inc. FY 2025 shares outstanding were 670,466, a +107.96% increase from FY 2024.

PAVmed Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +36.6% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

PAVM shares outstanding · 4 questions

As of December 31, 2025, PAVmed Inc. (PAVM) has approximately 670,466 basic shares outstanding and 670,466 diluted shares outstanding. This represents a +107.96% year-over-year increase from FY 2024 (322,407). The increase may reflect equity compensation issuances or secondary offerings.

PAVM shares outstandinghow many shares does PAVM havePAVM basic shares 2025PAVM diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · PAVmed Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09